New Therapeutic Options in Congestive Heart Failure: Part I

New therapeutic options in congestive heart failure: Part I.

New Therapeutic Options in Congestive Heart Failure: Part I Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2002 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/01.CIR.0000014763.63528.9D 2002;105:2099-2106 Circulation. http://circ.ahajournals.org/content/105/17/2099...

New therapeutic options in congestive heart failure: Part II.

Anticytokine and Immunomodulating Therapy Cytokines, such as tumor necrosis factor, are produced in increased amounts in a variety of tissues in patients with CHF.1 Higher plasma cytokine concentrations are associated with a worse prognosis.1 Experimentally, cytokines depress myocardial contractility, cause myocyte death, and induce heart failure.1 There is some evidence that anticytokine inter...

John McMurray and Marc A . Pfeffer New Therapeutic Options in Congestive Heart Failure : Part II

New Therapeutic Options in Congestive Heart Failure : Part II Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2002 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/01.CIR.0000014771.38666.22 2002;105:2223-2228 Circulation. http://circ.ahajournals.org/content/105/18/22...

Present treatment options in congestive heart failure.

CONGESTIVE HEART FAILURE IN CHILDREN: A SURVEY OF 114 PATIENTS

During a period of four years between June, IS, 1988 to June, IS, 1992 one hundred and fourteen patients with congestive heart failure (CHF) were admitted to the pediatric department of Taleghani General Hospital. During the above period, 192 patients with heart disease were hospitalized at this department and CHF was the cause of admission in 59.4% of them. Congenital heart disease (CHO) w...